Vagelos College of Physicians and Surgeons

Displaying 14201 - 14250 of 20166CSV
Mian, A., Wei, W., Chakraborty, R., Yi, J. C., Preussler, J. M., Hill, B. T., Cerny, J., Deol, A., Hahn, T. E., Hashmi, S. K., Jaglowski, S., Jim, H. S. L., Khera, N., Loren, A. W., McGuirk, J. P., Savani, B. N., Stiff, P., Uberti, J. P., Whalen, V., … Majhail, N. S. (2022). Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions. Blood, 140(Supplement 1), 8019–8021. https://doi.org/10.1182/blood-2022-167411
Publication Date
Mosialou, I., Ali, A. M., Adams, R., Corper, A., Woods, C. M., Fan, X., Raza, A., & Kousteni, S. (2022). Therapeutic Anti-Jagged1 Antibody Targeting Osteoblast-Related Myeloid Dysplasia to Overcome Standard of Care Resistance. Blood, 140(Supplement 1), 2902–2902. https://doi.org/10.1182/blood-2022-167042
Publication Date
Locatelli, F., Lang, P., Li, A., Corbacioglu, S., de la Fuente, J., Wall, D. A., Liem, R., Meisel, R., Mapara, M. Y., Shah, A. J., Cappellini, M. D. D., Kattamis, A., Sheth, S., Bobruff, Y., Bower, L., Zhang, L., Sharma, A., Song, Y., Hobbs, W., & Frangoul, H. (2022). Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia. Blood, 140(Supplement 1), 4899–4901. https://doi.org/10.1182/blood-2022-166881
Publication Date
Thomas, T., Qiu, A., Kim, C. Y., Gordy, D. E., Miller, A., Tredicine, M., Stone, E., Dzieciatkowska, M., Hod, E. A., D’Alessandro, A., Spitalnik, S. L., Zimring, J. C., Akpan, I. J., Luckey, C. J., & Hudson, K. E. (2022). Reticulocytes Are an Unappreciated Risk Factor for RBC Alloimmunization at the Donor and Recipient Levels. Blood, 140(Supplement 1), 75–76. https://doi.org/10.1182/blood-2022-169746
Publication Date
Capellini, A., Etra, A., Alousi, A. M., Al Malki, M. M., Choe, H., Defilipp, Z., Hogan, W. J., Kitko, C. L., Ayuk, F. A., Baez, J., Gandhi, I., Kasikis, S., Gleich, S., Hexner, E. O., Hoepting, M., Kapoor, U., Kowalyk, S., Kwon, D., Langston, A., … Levine, J. E. (2022). Effective Treatment of Low Risk Acute Gvhd with Itacitinib Monotherapy. Blood, 140(Supplement 1), 1867–1869. https://doi.org/10.1182/blood-2022-156000
Publication Date
Jajosky, R. P., Allen, J. W., Zerra, P. E., Maier, C. L., Chonat, S., Luckey, C. J., Roback, J. D., Fasano, R. M., Josephson, C. D., Manis, J. P., Chai, L., Hendrickson, J. E., Hudson, K. E., Arthur, C. M., & Stowell, S. R. (2022). Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression. Blood, 140(Supplement 1), 73–74. https://doi.org/10.1182/blood-2022-170081
Publication Date
Scalia, S., Toskic, D., Zhou, P., Mansukhani, M. M., Lee, L., Wong, S. W., Tuchman, S. A., Hoffman, J. E., Fogaren, T., Varga, C., Lentzsch, S., & Comenzo, R. (2022). The Clusterin/Von Willebrand Factor Ratio Is Significantly Lower in Marrow Plasma from AL λ-Type Than from λ-Isotype Monoclonal Gammopathy Patients. Blood, 140(Supplement 1), 10120–10121. https://doi.org/10.1182/blood-2022-162352
Publication Date
Mohyuddin, G. R., Chakraborty, R., Calip, G., Ascha, M. S., Wang, X., Rubinstein, S., Tuchman, S. A., Costa, L. J., Haaland, B., Giri, S., Mian, H. S., Fonseca, R., & Sborov, D. W. (2022). Prognostic Value of Translocation 11;14 in Patients with Relapsed/Refractory Myeloma Receiving Anti-CD38 Therapy. Blood, 140(Supplement 1), 5223–5224. https://doi.org/10.1182/blood-2022-165541
Publication Date
Hijiya, N., Kapoor, S., Hoch, M., Descamps, L., Dasgupta, K., & Ramscar, N. (2022). ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in Chronic Phase. Blood, 140(Supplement 1), 12204–12205. https://doi.org/10.1182/blood-2022-162451
Publication Date
Li, S., Fu, J., Yang, J., Ma, H., Mapara, M. Y., Marcireau, C., & Lentzsch, S. (2022). MAP4K2 Inhibition Reinforces the Iberdomide Sensitivity in MM Cells By Inducing IKZF1 Degradation through a CRBN Independent Mechanism. Blood, 140(Supplement 1), 4224–4225. https://doi.org/10.1182/blood-2022-168314
Publication Date
Torres-Diz, M., Thomas-Tikhonenko, A., Reglero, C., Ferrando, A., Falkenstein, C. D., Tasian, S. K., Sehgal, P., Ang, Z., Barash, Y., & Radens, C. (2022). Non-Canonical Exon Usage in Pediatric Leukemia: Implications for Chemoresistance. Blood, 140(Supplement 1), 3264–3265. https://doi.org/10.1182/blood-2022-167006
Publication Date
Lee, H. J., Choi, M. Y., Siddiqi, T., Rhodes, J. M., Wierda, W. G., Isufi, I., Tuscano, J. M., Lamanna, N., Subbiah, S., Koff, J. L., Leslie, L., Goldenberg, A., Chung, G. G., Breitmeyer, J. B., Yazji, S., Wang, M., Jamieson, C., & Kipps, T. J. (2022). Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL). Blood, 140(Supplement 1), 566–568. https://doi.org/10.1182/blood-2022-167153
Publication Date
Frangoul, H., Locatelli, F., Bhatia, M., Mapara, M. Y., Molinari, L., Sharma, A., Lobitz, S., de Montalembert, M., Rondelli, D., Steinberg, M., Walters, M. C., Imren, S., Zhang, L., Sharma, A., Song, Y., Simard, C., Hobbs, W., & Grupp, S. (2022). Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease. Blood, 140(Supplement 1), 29–31. https://doi.org/10.1182/blood-2022-162353
Publication Date
Orlando, E., Ford, M., Jin, Z., Lipsky, A. H., Sawas, A., Pro, B., & Amengual, J. E. (2022). The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation. Blood, 140(Supplement 1), 12085–12086. https://doi.org/10.1182/blood-2022-158050
Publication Date
Melody, M., St. Pierre, F., Helenowski, I., Pearse, W. B., Vakkalagadda, C. V., Leventhal, J. R., Friedewald, J., Ho, B., Ganger, D., Winter, J. N., Gordon, L. I., Lin, A. Y., Karmali, R., Ma, S., Pro, B., & Moreira, J. (2022). Impact of Extranodal Disease Involvement on Outcomes in Post-Transplant Lymphoproliferative Disorder. Blood, 140(Supplement 1), 6674–6675. https://doi.org/10.1182/blood-2022-164724
Publication Date
Qiu, A., Wang, L., Dei Zotti, F., Hudson, K. E., Hod, E. A., & La Carpia, F. (2022). Iron Overload and Iron-Induced Microbiome Changes May Affect Lymphoid Levels Post Bone Marrow Transplant and Graft-Versus-Host Disease Survival in Mice. Blood, 140(Supplement 1), 2465–2466. https://doi.org/10.1182/blood-2022-167300
Publication Date
Di Meo, F., Iyer, A., Akama, K., Yu, C., Cheng, R., Cesarano, A., Marino, S., Aljoufi, A., Soni, R., Roda, J. M., Sissons, J., Vu, L. P., Guzman, M. L., Huang, K., Roodman, D. G., & Perna, F. (2022). A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma. Blood, 140(Supplement 1), 671–672. https://doi.org/10.1182/blood-2022-167584
Publication Date
Stiefel, J., Flower, A. M., Botwinick, M., Ford, M., Foti, A., Gandhi, M., Slovin, J., Smilow, E., Bowers, A., Karpel, H., Schwartz, L. Y., Fraint, E., Gennarini, L. M., Gardner, S. L., Raetz, E. A., Shah, N. C., Chen, J., Krajewski, J., Hijiya, N., … Sulis, M. L. (2022). Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL. Blood, 140(Supplement 1), 7763–7765. https://doi.org/10.1182/blood-2022-160272
Publication Date
Melody, M., St. Pierre, F., Helenowski, I., Pearse, W. B., Vakkalagadda, C., Leventhal, J. R., Ho, B., Friedewald, J., Ganger, D., Winter, J. N., Gordon, L. I., Lin, A. Y., Karmali, R., Ma, S., Pro, B., & Moreira, J. (2022). Posttransplant Lymphoproliferative Disorder (PTLD) Following Transplantation at Northwestern University: Choice of Immunosuppressive Agents Does Not Impact Outcomes in PTLD. Blood, 140(Supplement 1), 3833–3834. https://doi.org/10.1182/blood-2022-167812
Publication Date
Balamurugan, M. A., Desiraju, S., Wojczyk, B. S., Namachivayam, K., Chung, Y., Guzman, P., & Krishnan, M. (2022). RBC Transfusion to Severe Anemic Murine Neonates Leads to Systemic Inflammation. Blood, 140(Supplement 1), 5702–5703. https://doi.org/10.1182/blood-2022-159574
Publication Date
Chapman-Fredricks, J. R., Thakkar, D., Alderuccio, J. P., Naresh, K. N., Ondrejka, S. L., Hsi, E. D., Xu, M. L., Paulson, N., Koff, J. L., Jaye, D. L., Cohen, J. B., Ortved Gang, A., Leeman-Neill, R. J., Dave, T., Happ, L., Love, C., Zandi, S., Naushad, H., Mason, E. F., … Lossos, I. S. (2022). Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site. Blood, 140(Supplement 1), 6378–6380. https://doi.org/10.1182/blood-2022-165616
Publication Date
Lewiecki, E. M., Bilezikian, J. P., Binkley, N., Bouxsein, M. L., Bukata, S. V., Dempster, D. W., Drake, M. T., McClung, M. R., Miller, P. D., Rosenthal, E., & Tosi, L. L. (2022). Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases. Journal of Clinical Densitometry, 25(4), 649–667. https://doi.org/10.1016/j.jocd.2022.10.002
Publication Date
Estrella, B., Pazos, M. A., Ricker, E. C., Ryu, Y. K., Piorczynski, T. B., Liu, Y., Tolu, S., & Amengual, J. E. (2022). First-in-Class Histone Acetyltransferase (HAT) Activator, YF2, Modulates Immune Evasion in DLBCL, Enhancing the Effects of Immune Checkpoint Blockade. Blood, 140(Supplement 1), 358–359. https://doi.org/10.1182/blood-2022-166929
Publication Date
Breyer, L. M., Wang, H., Gu, D., Johnstone, B. H., Ma, H., Woods, E. J., & Mapara, M. Y. (2022). Transplantation of Hematopoietic Stem and Progenitor Cells from Cadaveric Organ Donors Leads to Long-Term Multilineage Engraftment in NSG Mice. Blood, 140(Supplement 1), 7347–7348. https://doi.org/10.1182/blood-2022-169787
Publication Date
Yu, L., Hsieh, Y.-C., Pearse, R. V., Wang, Y., Petyuk, V. A., Schneider, J. A., Buchman, A. S., Seyfried, N. T., De Jager, P. L., Young-Pearse, T. L., & Bennett, D. A. (2022). Association of AK4 Protein From Stem Cell–Derived Neurons With Cognitive Reserve. Neurology, 99(20). https://doi.org/10.1212/wnl.0000000000201120
Publication Date
Pawlaczyk, W., Rogowski, L., Kowalska, J., Stefańska, M., Gołębiowski, T., Mazanowska, O., Gerall, C., Krajewska, M., Kusztal, M., & Dziubek, W. (2022). Assessment of the Nutritional Status and Quality of Life in Chronic Kidney Disease and Kidney Transplant Patients: A Comparative Analysis. Nutrients, 14(22), 4814. https://doi.org/10.3390/nu14224814
Publication Date
Ruscica, A., Rogers, J., & Stokes, S. (2022). A Qualitative Study Assessing Haitian Pediatric Nursing Educational Needs in Port-au-Prince, Haiti. American Journal of Tropical Medicine and Hygiene, 107(5), 1137–1141. https://doi.org/10.4269/ajtmh.22-0299
Publication Date
Tavakol, D. N., Fleischer, S., Falcucci, T., Graney, P. L., Halligan, S. P., Kaplan, D. L., & Vunjak-Novakovic, G. (2021). Emerging Trajectories for Next Generation Tissue Engineers. ACS Biomaterials Science & Engineering, 8(11), 4598–4604. https://doi.org/10.1021/acsbiomaterials.1c01428
Publication Date
Noguchi, M., Gkargkoulas, F., Matsumura, M., Kotinkaduwa, L. N., Hu, X., Usui, E., Fujimura, T., Seike, F., Salem, H., Jin, G., Li, C., Yamamoto, K., Sato, T., Redfors, B., Fall, K. N., Nazif, T. M., Ali, Z. A., Karmpaliotis, D., Parikh, S. A., … Maehara, A. (2022). Impact of Nonobstructive Left Main Coronary Artery Atherosclerosis on Long-Term Mortality. JACC: Cardiovascular Interventions, 15(21), 2206–2217. https://doi.org/10.1016/j.jcin.2022.08.024
Publication Date
Mirza, F. G., Tahlak, M. A., Rjeili, R. B., Hazari, K., Ennab, F., Hodgman, C., Khamis, A. H., & Atiomo, W. (2022). Polycystic Ovarian Syndrome (PCOS): Does the Challenge End at Conception? International Journal of Environmental Research and Public Health, 19(22), 14914. https://doi.org/10.3390/ijerph192214914
Publication Date
Moin, S. M., Boyington, J. C., Boyoglu-Barnum, S., Gillespie, R. A., Cerutti, G., Cheung, C. S.-F., Cagigi, A., Gallagher, J. R., Brand, J., Prabhakaran, M., Tsybovsky, Y., Stephens, T., Fisher, B. E., Creanga, A., Ataca, S., Rawi, R., Corbett, K. S., Crank, M. C., Karlsson Hedestam, G. B., … Kanekiyo, M. (2022). Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. Immunity, 55(12), 2405-2418.e7. https://doi.org/10.1016/j.immuni.2022.10.015
Publication Date
Hirsch, J. A., Michael, Y. L., Moore, K. A., Melly, S., Hughes, T. M., Hayden, K., Luchsinger, J. A., Jimenez, M. P., James, P., Besser, L. M., Sánchez, B., & Diez Roux, A. V. (2022). Longitudinal neighbourhood determinants with cognitive health and dementia disparities: protocol of the Multi-Ethnic Study of Atherosclerosis Neighborhoods and Aging prospective cohort study. BMJ Open, 12(11), e066971. https://doi.org/10.1136/bmjopen-2022-066971
Publication Date
Horesh, D., Kohavi, S., Shilony-Nalaboff, L., Rudich, N., Greenman, D., Feuerstein, J. S., & Abbasi, M. R. (2022). Virtual Reality Combined with Artificial Intelligence (VR-AI) Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study. Healthcare, 10(11), 2261. https://doi.org/10.3390/healthcare10112261
Publication Date
Hershman, D. L., Unger, J. M., Greenlee, H., Capodice, J., Lew, D. L., Darke, A., Minasian, L. M., Fisch, M. J., Henry, N. L., & Crew, K. D. (2022). Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain. JAMA Network Open, 5(11), e2241720. https://doi.org/10.1001/jamanetworkopen.2022.41720
Publication Date
Kreski, N. T., Cerdá, M., Chen, Q., Hasin, D. S., Martins, S. S., Mauro, P. M., Olfson, M., & Keyes, K. M. (2022). Adolescents’ Use of Free Time and Associations with Substance Use from 1991 to 2019. Substance Use & Misuse, 57(13), 1893–1903. https://doi.org/10.1080/10826084.2022.2115849
Publication Date
Kim, W., Hecker, J., Barr, R. G., Boerwinkle, E., Cade, B., Correa, A., Dupuis, J., Gharib, S. A., Lange, L., London, S. J., Morrison, A. C., O’Connor, G. T., Oelsner, E. C., Psaty, B. M., Vasan, R. S., Redline, S., Rich, S. S., Rotter, J. I., … Yu, B. (2022). Assessing the contribution of rare genetic variants to phenotypes of chronic obstructive pulmonary disease using whole-genome sequence data. Human Molecular Genetics, 31(22), 3873–3885. https://doi.org/10.1093/hmg/ddac117
Publication Date
Benasi, G., Gostoli, S., Zhu, B., Offidani, E., Artin, M. G., Gagliardi, L., Rignanese, G., Sassi, G., Fava, G. A., & Rafanelli, C. (2022). Well-Being Therapy and Lifestyle Intervention in Type 2 Diabetes: A Pilot Randomized Controlled Trial. Psychosomatic Medicine, 84(9), 1041–1049. https://doi.org/10.1097/psy.0000000000001115
Publication Date
Woo, J. L., DiLorenzo, M. P., Rosenzweig, E., Pasumarti, N., Villeda, G. V., Berman-Rosenzweig, E., & Krishnan, U. (2022). Correlation Between Right Ventricular Echocardiography Measurements and Functional Capacity in Patients With Pulmonary Arterial Hypertension. Texas Heart Institute Journal, 49(6). https://doi.org/10.14503/thij-21-7719
Publication Date

Reyes C, Pistillo A, Fernández-Bertolín S, et al (2021). Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. BMJ Open, 11:e057632. doi:10.1136/bmjopen-2021-057632

Publication Date
Wang, Q., Iketani, S., Li, Z., Guo, Y., Yeh, A. Y., Liu, M., Yu, J., Sheng, Z., Huang, Y., Liu, L., & Ho, D. D. (2022). Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75. Cell Host & Microbe, 30(11), 1512-1517.e4. https://doi.org/10.1016/j.chom.2022.09.002
Publication Date

Vagelos College of Physicians and Surgeons